Buy Cagri-Reta 5mg Online

Cagri-Reta pairs cagrilintide, a long-acting acylated amylin analog, with retatrutide, a triple agonist at the GIP, GLP-1 and glucagon receptors. The logic is additive coverage of appetite and energy expenditure through mechanisms that do not overlap. Retatrutide is the broadest incretin in this catalog: the GLP-1 arm slows gastric emptying and acts on hypothalamic satiety neurons, the GIP arm adds insulinotropic effect and adipose insulin sensitivity, and the glucagon arm — unusual in this drug class, since glucagon raises blood sugar — contributes to hepatic fat mobilisation and resting energy expenditure. Cagrilintide contributes a fourth, entirely separate signal through amylin and calcitonin receptors in the brainstem area postrema. Every component here carries a fatty acid chain for albumin binding, so all of them share the extended half-life that makes weekly dosing viable in the published literature. This 5mg vial is the smaller of the two Cagri-Reta listings and is the sensible entry point for characterising a blend before committing to the larger vial.